Clinical trial Recruiting at 1 site Observational Ages 30 to 80

Examining brain changes in patients with essential tremor receiving deep brain stimulation

Official title: Functional Brain Network Changes in Patients Undergoing Deep Brain Stimulation for Essential Tremor

Run by The Cleveland Clinic · NCT06293638 · Data updated 2026-11-12

This study is testing how deep brain stimulation affects brain activity in people with essential tremor to find better ways to manage their symptoms.

Quick facts

Study typeObservational
Ages30 Years to 80 Years
SexAll
Enrollment55 (estimated)
SponsorThe Cleveland Clinic
Academic / other
Locations1 site (Cleveland, Ohio)
StatusRecruiting
StartedMarch 25, 2024
Main results expectedDecember 31, 2028
Study endsDecember 31, 2028
Registry record updatedMay 8, 2026
Trial IDNCT06293638 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 30 to 80 with a clinical diagnosis of essential tremor and a disease duration of at least 3 years.

Probably not a fit

Patients with significant psychiatric symptoms or cognitive impairments may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to collect electrophysiological data to understand how deep brain stimulation (DBS) affects brain networks in patients with essential tremor. Participants will undergo either electroencephalography (EEG) or magnetoencephalography (MEG) to record brain activity during different states of DBS, including optimal and sub-optimal settings. The study will also explore the effects of non-DBS tremor mitigation techniques, such as medication and cooling therapies. By analyzing these data, researchers hope to identify new therapeutic targets to improve tremor control.

Why it matters

Potential benefit: If successful, this study could lead to improved treatment strategies for patients with essential tremor.

How similar studies have gone: Other studies have shown promise in understanding brain network changes with DBS, making this approach both relevant and potentially impactful.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Between 30 and 80 years of age;
* Ability to provide informed consent;
* Clinical diagnosis of ET by a movement disorders neurologist with a disease duration of at least 3 years and being treated with a DBS; OR
* Clinical diagnosis of ET by a movement disorders neurologist with a disease duration of at least 3 years and not being treated with a DBS; OR
* No known neurological disease or disorder.

Exclusion Criteria:

* The individual has a condition that, in the opinion of the investigator, would significantly increase the risk for interference with study compliance, safety, or outcome;
* Presence of active psychiatric symptoms meeting Diagnostic and Statistical Manual of Mental Disorders-4th Edition (DSM-IV) criteria for Axis-I disorder on formal psychiatric evaluation other than depression or anxiety;
* History of cognitive impairment meeting Diagnostic and Statistical Manual of Mental Disorders-4th Edition (DSM-IV) criteria for dementia on formal neuropsychological evaluation, as documented in chart;
* Lack of English-language fluency which would interfere with the ability to understand the study consenting process and potential study risks;
* Hearing or visual impairment precluding testing;
* Motor impairment impacting test responses (i.e., orthopedic injury or disease);
* Anyone currently taking medications with Antabuse-like effects (e.g. Flagyl, Bactrim, Tindamax) will be excluded from any alcohol administration.

Where it's running

  • Cleveland Clinic
    Cleveland, Ohio, United States
    Recruiting

Study contacts

  • Principal investigator: James Liao, MD — The Cleveland Clinic
  • Study coordinator: Jeffrey Negrey, MA
  • Email: negreyj2@ccf.org
  • Phone: 2163166896

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.